Search Results - "GRDADOLNIK, Simona Golic"

Refine Results
  1. 1

    Polymorphisms of CYP51A1 from cholesterol synthesis: associations with birth weight and maternal lipid levels and impact on CYP51 protein structure by Lewińska, Monika, Zelenko, Urska, Merzel, Franci, Golic Grdadolnik, Simona, Murray, Jeffrey C, Rozman, Damjana

    Published in PloS one (17-12-2013)
    “…We investigated the housekeeping cytochrome P450 CYP51A1 encoding lanosterol 14α-demethylase from cholesterol synthesis that was so far not directly linked to…”
    Get full text
    Journal Article
  2. 2

    Evaluation of Selected CYP51A1 Polymorphisms in View of Interactions with Substrate and Redox Partner by Režen, Tadeja, Ogris, Iza, Sever, Marko, Merzel, Franci, Golic Grdadolnik, Simona, Rozman, Damjana

    Published in Frontiers in pharmacology (30-06-2017)
    “…Cholesterol is essential for development, growth, and maintenance of organisms. Mutations in cholesterol biosynthetic genes are embryonic lethal and few…”
    Get full text
    Journal Article
  3. 3

    NMR and Molecular Dynamics Study of the Binding Mode of Naphthalene-N-sulfonyl-d-glutamic Acid Derivatives: Novel MurD Ligase Inhibitors by Simčič, Mihael, Hodošček, Milan, Humljan, Jan, Kristan, Katja, Urleb, Uroš, Kocjan, Darko, Grdadolnik, Simona Golič

    Published in Journal of medicinal chemistry (14-05-2009)
    “…The presented series of naphthalene-N-sulfonyl-d-glutamic acid derivatives are novel MurD ligase inhibitors with moderate affinity that occupy the d-Glu…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Distinct conformational changes occur within the intrinsically unstructured pro‐domain of pro‐Nerve Growth Factor in the presence of ATP and Mg2 by Paoletti, Francesca, Covaceuszach, Sonia, Cassetta, Alberto, Calabrese, Antonio N., Novak, Urban, Konarev, Petr, Grdadolnik, Jože, Lamba, Doriano, Golič Grdadolnik, Simona

    Published in Protein science (01-02-2023)
    “…Nerve growth factor (NGF), the prototypical neurotrophic factor, is involved in the maintenance and growth of specific neuronal populations, whereas its…”
    Get full text
    Journal Article
  6. 6

    New Class of Hsp90 C‑Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer by Zajec, Živa, Dernovšek, Jaka, Cingl, Jernej, Ogris, Iza, Gedgaudas, Marius, Zubrienė, Asta, Mitrović, Ana, Golič Grdadolnik, Simona, Gobec, Martina, Tomašič, Tihomir

    Published in Journal of medicinal chemistry (08-08-2024)
    “…Triple-negative breast cancer (TNBC) remains a treatment challenge and requires innovative therapies. Hsp90, crucial for the stability of numerous oncogenic…”
    Get full text
    Journal Article
  7. 7

    Determination of Conformational Preferences of Dipeptides Using Vibrational Spectroscopy by Grdadolnik, Jože, Golič Grdadolnik, Simona, Avbelj, Franc

    Published in The journal of physical chemistry. B (06-03-2008)
    “…The NMR coupling constants (3 J(HN, Hα)) of dipeptides indicate that the backbone conformational preferences vary strikingly among dipeptides. These…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Nature-inspired substituted 3-(imidazol-2-yl) morpholines targeting human topoisomerase IIα: Dynophore-derived discovery by Herlah, Barbara, Janežič, Matej, Ogris, Iza, Grdadolnik, Simona Golič, Kološa, Katja, Žabkar, Sonja, Žegura, Bojana, Perdih, Andrej

    Published in Biomedicine & pharmacotherapy (01-06-2024)
    “…The molecular nanomachine, human DNA topoisomerase IIα, plays a crucial role in replication, transcription, and recombination by catalyzing topological changes…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα by Janežič, Matej, Valjavec, Katja, Loboda, Kaja Bergant, Herlah, Barbara, Ogris, Iza, Kozorog, Mirijam, Podobnik, Marjetka, Grdadolnik, Simona Golič, Wolber, Gerhard, Perdih, Andrej

    “…In this study, we utilized human DNA topoisomerase IIα as a model target to outline a dynophore-based approach to catalytic inhibitor design. Based on MD…”
    Get full text
    Journal Article
  13. 13

    Unveiling the interaction profile of rosmarinic acid and its bioactive substructures with serum albumin by Papaemmanouil, Christina, Chatziathanasiadou, Maria V., Chatzigiannis, Christos, Chontzopoulou, Eleni, Mavromoustakos, Thomas, Grdadolnik, Simona Golic, Tzakos, Andreas G.

    “…Rosmarinic acid, a phytochemical compound, bears diverse pharmaceutical profile. It is composed by two building blocks: caffeic acid and a salvianic acid unit…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Revealing the astragalin mode of anticandidal action by Ivanov, Marija, Kannan, Abhilash, Stojkovic, Dejan, Glamoclija, Jasmina, Golic Grdadolnik, Simona, Sanglard, Dominique, Sokovic, Marina

    Published in EXCLI journal (01-01-2020)
    “…Due to limited arsenal of systemically available antifungal agents, infections caused by are difficult to treat and the emergence of drug-resistant strains…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Intrinsic Backbone Preferences Are Fully Present in Blocked Amino Acids by Avbelj, Franc, Grdadolnik, Simona Golic, Grdadolnik, Joze, Baldwin, Robert L.

    “…The preferences of amino acid residues for Φ,ψ backbone angles vary strikingly among the amino acids, as shown by the backbone angle Φ found from…”
    Get full text
    Journal Article
  19. 19

    NMR in the design of antibacterials by Arsovska, Emilija, Mali, Gregor, Golič Grdadolnik, Simona, Zega, Anamarija

    Published in Current medicinal chemistry (01-01-2014)
    “…One of the most challenging areas in drug design is the area of new antibacterial drugs. Despite significant progress in target validation and screening…”
    Get more information
    Journal Article
  20. 20

    Structural Insight into the Unique Binding Properties of Pyridylethanol(phenylethyl)amine Inhibitor in Human CYP51 by Zelenko, Urška, Hodošček, Milan, Rozman, Damjana, Golič Grdadolnik, Simona

    “…Sterol 14α-demethylase (CYP51) is the main drug target for the treatment of fungal infections. The discovery of new efficient fungal CYP51 inhibitors requires…”
    Get full text
    Journal Article